Francesco Circosta
Francesco Circosta is an expert in Cardiology at Sapienza University of Rome (Italy). Francesco Circosta has authored 31 publications, the most recent in 2026. SLR score: 63 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Endocrinology - Biochemistry - Hematology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2021 - 2026
Number : 31
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Combined SGLT-2 Inhibitor and Mineralocorticoid Receptor Antagonist Therapy: Effects on the Renin-Angiotensin-Aldosterone System in Heart Failure Treatment. PMID 42883770 — diabetes mellitus, kidney diseases, sodium-glucose transporter 2 inhibitors, aldosterone, heart failure, heart, albuminuria, treatment failure, renin, receptors, mineralocorticoid, angiotensins, therapeutics, mineralocorticoids, mineralocorticoid receptor antagonists, diabetes mellitus, type 2 | Int J Mol Sci | 2026 | 0 |
| The Interplay Between Klotho, Aldosterone, and Vascular Damage in Chronic Kidney Disease: Insights from a Cross-Sectional Study. PMID 42816442 — kidney diseases, aldosterone, cross-sectional studies, ankle, kidney, nephrology, kidney transplantation | J Nephrol | 2026 | 0 |
| Temporal changes in cortisol secretion and their association with long-term outcomes in benign adrenal incidentalomas: a retrospective cohort study. PMID 42413529 — diabetes mellitus, hypertension, mortality, incidental findings, cohort studies, risk factors, diagnosis, hydrocortisone | Lancet Diabetes Endocrinol Top journal | 2026 | 2 |
| Juvenile nasopharyngeal angiofibroma: analysis of 12 cases and review of the literature. PMID 42109908 — growth, vascular endothelial growth factor a, tumor necrosis factor-alpha, neoplasms, angiofibroma, therapeutics, tissues | Open Med (Wars) | 2026 | 0 |
| Thrombaxane-B2 as a predictor marker of atrial fibrillation. PMID 41809734 — diabetes mellitus, sleep apnea, obstructive, arrhythmias, cardiac, atrial fibrillation, sleep apnea syndromes, diabetes mellitus, type 2 | Int J Cardiol Cardiovasc Risk Prev | 2026 | 0 |
LeadR Networks
Main global connection map